EVINACUMAB-DGNB for Type iia hyperlipidaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 50 adverse event reports in the FDA FAERS database where EVINACUMAB-DGNB was used for Type iia hyperlipidaemia.
Most Reported Side Effects for EVINACUMAB-DGNB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Nausea | 14 | 15.2% | 0 | 1 |
| Fatigue | 12 | 13.0% | 0 | 2 |
| Pain | 9 | 9.8% | 0 | 1 |
| Hepatic steatosis | 7 | 7.6% | 0 | 0 |
| Diarrhoea | 6 | 6.5% | 0 | 0 |
| Dizziness | 6 | 6.5% | 0 | 0 |
| Drug ineffective | 6 | 6.5% | 0 | 1 |
| International normalised ratio increased | 6 | 6.5% | 0 | 0 |
| Product dose omission issue | 6 | 6.5% | 0 | 0 |
| Death | 5 | 5.4% | 5 | 0 |
| Headache | 5 | 5.4% | 0 | 0 |
Other Indications for EVINACUMAB-DGNB
Other Drugs Used for Type iia hyperlipidaemia
EVOLOCUMAB (5,556)
LOMITAPIDE (3,314)
ALIROCUMAB (1,913)
ATORVASTATIN (637)
EZETIMIBE (562)
ROSUVASTATIN (547)
INCLISIRAN (313)
SIMVASTATIN (294)
PRAVASTATIN (152)
JUXTAPID (145)